US first for peripheral vessel beta radiation trial:
This article was originally published in Clinica
Radiance Medical Systems has enrolled the first patients into a US trial to assess its intravascular beta radiation system as a treatment for restenosis in peripheral vessels. The Irvine, California, firm believes the study, called RAPID, represents the first use of beta radiation in the US to treat arterial stenosis in a peripheral vessel. The trial, which is also being conducted at centres in Europe, is testing Radiance's RDX balloon based system, which the company suggests may provide a better treatment for peripheral lesions than other technologies, including current vascular brachytherapy or drug-eluting stents.